Lindbrook Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$3.06M Buy
6,308
+5,202
+470% +$2.52M 0.28% 53
2024
Q4
$445K Sell
1,106
-28,526
-96% -$11.5M 0.04% 242
2024
Q3
$13.8M Buy
29,632
+7,872
+36% +$3.66M 1.22% 13
2024
Q2
$10.2M Sell
21,760
-8,428
-28% -$3.95M 0.96% 16
2024
Q1
$12.6M Buy
30,188
+18,996
+170% +$7.94M 1.18% 14
2023
Q4
$4.55M Buy
11,192
+5,161
+86% +$2.1M 0.45% 42
2023
Q3
$2.1M Sell
6,031
-5,345
-47% -$1.86M 0.23% 65
2023
Q2
$4M Sell
11,376
-20,406
-64% -$7.18M 0.43% 42
2023
Q1
$10M Sell
31,782
-157
-0.5% -$49.5K 1.17% 11
2022
Q4
$9.22M Buy
31,939
+24,198
+313% +$6.99M 1.14% 12
2022
Q3
$2.24M Buy
7,741
+3,208
+71% +$929K 0.38% 31
2022
Q2
$1.28M Buy
4,533
+1,762
+64% +$496K 0.21% 64
2022
Q1
$723K Buy
2,771
+1,749
+171% +$456K 0.11% 115
2021
Q4
$224K Buy
1,022
+536
+110% +$117K 0.03% 281
2021
Q3
$88K Sell
486
-23
-5% -$4.17K 0.02% 292
2021
Q2
$103K Sell
509
-14
-3% -$2.83K 0.02% 288
2021
Q1
$112K Buy
523
+11
+2% +$2.36K 0.03% 250
2020
Q4
$121K Sell
512
-46
-8% -$10.9K 0.03% 208
2020
Q3
$152K Buy
558
+64
+13% +$17.4K 0.04% 153
2020
Q2
$143K Sell
494
-8
-2% -$2.32K 0.04% 158
2020
Q1
$119K Sell
502
-164
-25% -$38.9K 0.05% 166
2019
Q4
$146K Sell
666
-65
-9% -$14.2K 0.05% 189
2019
Q3
$124K Sell
731
-15
-2% -$2.54K 0.05% 200
2019
Q2
$136K Buy
746
+17
+2% +$3.1K 0.05% 184
2019
Q1
$134K Hold
729
0.05% 180
2018
Q4
$120K Buy
+729
New +$120K 0.06% 169